Abstract
The technology available for the support of pharmaceutical company drug information department activities in 1970 is described as a baseline for enumerating and evaluating the fundamental and profound technological changes of the final three decades of the twentieth century. These changes have altered rates and methods of accessing drug information, approaches taken in evaluating information, and the speed at which information is provided to inquirers. These alterations, and the accompanying changes in the nature and quality of drug information services currently provided, are discussed in detail.
Get full access to this article
View all access options for this article.
